Molecular therapeutic strategies for spinal muscular atrophies: current and future clinical trials

Clinical Therapeutics
Chiara ZanettaStefania Corti

Abstract

Spinal muscular atrophy (SMA) is an autosomal recessive motor neuron disease caused by mutations in the survival motor neuron gene (SMN1) and the leading genetic cause of infant mortality. Currently, there is no effective treatment other than supportive care. This article provides a general overview of the main aspects that need to be taken into account to design a more efficient clinical trial and to summarize the most promising molecular trials that are currently in development or are being planned for the treatment of SMA. A systematic review of the literature was performed, identifying key clinical trials involving novel molecular therapies in SMA. In addition, abstracts presented at the meetings of the Families of Spinal Muscular Atrophy were searched and the Families of Spinal Muscular Atrophy Web site was carefully analyzed. Finally, a selection of SMA clinical trials registered at clinical-trials.gov has been included in the article. The past decade has seen a marked advancement in the understanding of both SMA genetics and molecular mechanisms. New molecules targeting SMN have shown promise in preclinical studies, and various clinical trials have started to test the drugs that were discovered through basic research. Bo...Continue Reading

References

Jan 1, 1992·Neuromuscular Disorders : NMD·T L Munsat, K E Davies
Jul 13, 2002·American Journal of Medical Genetics·Shuji OginoRobert B Wilson
Apr 27, 2005·Annals of Neurology·Kathryn J SwobodaMark B Bromberg
Apr 17, 2007·Neuromuscular Disorders : NMD·F D TizianoC Brahe
May 15, 2007·The Journal of Pharmacology and Experimental Therapeutics·Thierry BordetRebecca M Pruss
Sep 1, 2007·Journal of Child Neurology·Ching H WangUNKNOWN Participants of the International Conference on SMA Standard of Care
Oct 9, 2008·ACS Chemical Biology·Jasbir SinghMark E Gurney
Sep 11, 2010·Current Opinion in Pediatrics·Thomas W Prior
Mar 4, 2011·Science Translational Medicine·Marco A PassiniSeng H Cheng
Apr 13, 2011·Archives of Neurology·Stephen J Kolb, John T Kissel
Jul 26, 2011·The Journal of Clinical Investigation·Cathleen M LutzUmrao R Monani
Apr 21, 2012·Lancet Neurology·Eugenio MercuriSusan T Iannaccone
Apr 3, 2013·Human Gene Therapy·Paul N Porensky, Arthur H M Burghes
Jul 10, 2013·Muscle & Nerve·Stefan J CanoUNKNOWN International Coordinating Committee for SMA Clinical Trials Rasch Task Force

❮ Previous
Next ❯

Citations

Sep 24, 2014·Current Treatment Options in Neurology·Diana Castro, Susan T Iannaccone
Mar 14, 2014·Expert Opinion on Biological Therapy·Aleksander TouznikToshifumi Yokota
Dec 19, 2015·Cellular and Molecular Life Sciences : CMLS·Chiara SimoneStefania Corti
Aug 8, 2015·Journal of Genetic Counseling·Amanda Carré, Candice Empey
Aug 19, 2015·Current Opinion in Pharmacology·Graham McClorey, Matthew J Wood
May 29, 2015·Neurobiology of Disease·Shilpa PrabhakarXandra O Breakefield
Oct 4, 2015·Journal of the Neurological Sciences·Kay W NgCraig M Zaidman
Nov 27, 2014·Annals of Neurology·Michele A ScullyJennifer M Kwon
Apr 17, 2016·Journal of Genetic Counseling·Rebecca R MoultrieMegan A Lewis
Apr 17, 2016·Nucleic Acids Research·Rudolph L Juliano
May 6, 2016·Annual Review of Chemical and Biomolecular Engineering·Christopher E Nelson, Charles A Gersbach
Nov 12, 2016·Nature Reviews. Drug Discovery·Yasuko OnoHiroyuki Sorimachi
Jul 6, 2016·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jennifer Cj ChenKathryn R Wagner
Jun 21, 2017·Biochimica Et Biophysica Acta. General Subjects·Ashley Chin, Eric Lécuyer
Jan 8, 2016·Dose-response : a Publication of International Hormesis Society·Volkan GurelJohn McMichael
Oct 6, 2017·Genes·Nancy Martínez-MontielRebeca D Martínez-Contreras
Aug 19, 2017·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Shaoqing HeThomas Yorio
Feb 6, 2018·European Journal of Human Genetics : EJHG·Sabina GainottiDomenica Taruscio
Dec 31, 2015·Biochemistry Insights·Yanling ZhangYuanyuan Xiao
Oct 20, 2018·RNA Biology·Songhee H KimHye Yoon Park
Sep 8, 2016·Nature Medicine·Stanley Chun-Wei Lee, Omar Abdel-Wahab
Dec 12, 2019·The Cochrane Database of Systematic Reviews·Renske I WadmanAlexander Fje Vrancken
Feb 2, 2020·The Cochrane Database of Systematic Reviews·Renske I WadmanAlexander Fje Vrancken
Aug 19, 2015·Current Opinion in Neurology·Silvana Jirka, Annemieke Aartsma-Rus
Aug 24, 2018·Nature Reviews. Clinical Oncology·Alec PaschalisJohann S de Bono
Jun 28, 2019·Gene Therapy·Rithu PattaliXue-Jun Li
Apr 30, 2019·Frontiers in Neuroscience·Rachel WaltersG Gregory Neely
Oct 15, 2019·Frontiers in Genetics·Alireza ShahryariHeiko Lickert
Oct 7, 2017·Current Neurology and Neuroscience Reports·Diana Bharucha-Goebel, Petra Kaufmann
Apr 2, 2020·Yonsei Medical Journal·Qing Li
Oct 16, 2016·Journal of Applied Microbiology·F Khan, S F Oloketuyi
Feb 14, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Timothy J RobinsonSteven R Patierno
Feb 17, 2021·The Journal of Gene Medicine·Ankur Gadgil, Katarzyna Dorota Raczyńska
Aug 28, 2021·International Journal of Molecular Sciences·Li Chuin ChongSy-Bing Choi

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Cajal Bodies & Gems

Cajal bodies or coiled bodies are dense foci of coilin protein. Gemini of Cajal bodies, or gems, are microscopically similar to Cajal bodies. It is believed that Cajal bodies play important roles in RNA processing while gems assist the Cajal bodies. Find the latest research on Cajal bodies and gems here.

© 2021 Meta ULC. All rights reserved